TY - JOUR
T1 - Insulin receptor isoforms
T2 - an integrated view focused on gestational diabetes mellitus
AU - Westermeier, F.
AU - Sáez , T.
AU - Arroyo, P.
AU - Toledo, F.
AU - Gutierrez, J.
AU - Sanhueza, C.
AU - Pardo, F.
AU - Leiva, A.
AU - Sobrevia, L.
PY - 2016/5
Y1 - 2016/5
N2 - The human insulin receptor (IR) exists in two isoforms that differ by the absence (IR-A) or the presence (IR-B) of a 12-amino acid segment encoded by exon 11. Both isoforms are functionally distinct regarding their binding affinities and intracellular signalling. However, the underlying mechanisms related to their cellular functions in several tissues are only partially understood. In this review, we summarize the current knowledge in this field regarding the alternative splicing of IR isoform, tissue-specific distribution and signalling both in physiology and disease, with an emphasis on the human placenta in gestational diabetes mellitus (GDM). Furthermore, we discuss the clinical relevance of IR isoforms highlighted by findings that show altered insulin signalling due to differential IR-A and IR-B expression in human placental endothelium in GDM pregnancies. Future research and clinical studies focused on the role of IR isoform signalling might provide novel therapeutic targets for treating GDM to improve the adverse maternal and neonatal outcomes. Copyright (c) 2015 John Wiley & Sons, Ltd.
AB - The human insulin receptor (IR) exists in two isoforms that differ by the absence (IR-A) or the presence (IR-B) of a 12-amino acid segment encoded by exon 11. Both isoforms are functionally distinct regarding their binding affinities and intracellular signalling. However, the underlying mechanisms related to their cellular functions in several tissues are only partially understood. In this review, we summarize the current knowledge in this field regarding the alternative splicing of IR isoform, tissue-specific distribution and signalling both in physiology and disease, with an emphasis on the human placenta in gestational diabetes mellitus (GDM). Furthermore, we discuss the clinical relevance of IR isoforms highlighted by findings that show altered insulin signalling due to differential IR-A and IR-B expression in human placental endothelium in GDM pregnancies. Future research and clinical studies focused on the role of IR isoform signalling might provide novel therapeutic targets for treating GDM to improve the adverse maternal and neonatal outcomes. Copyright (c) 2015 John Wiley & Sons, Ltd.
KW - insulin receptor
KW - gestational diabetes
KW - placenta
KW - GROWTH-FACTOR-II
KW - UMBILICAL VEIN ENDOTHELIUM
KW - AMINO-ACID-TRANSPORT
KW - DIFFERENTIAL GENE-EXPRESSION
KW - REDUCED ADENOSINE TRANSPORT
KW - PRIMARY HUMAN TROPHOBLASTS
KW - SLC29A1 PROMOTER ACTIVITY
KW - L-ARGININE TRANSPORT
KW - HAMSTER OVARY CELLS
KW - EXON 11 INCLUSION
U2 - 10.1002/dmrr.2729
DO - 10.1002/dmrr.2729
M3 - Review article
SN - 1520-7560
VL - 32
SP - 350
EP - 365
JO - Diabetes-Metabolism research and reviews
JF - Diabetes-Metabolism research and reviews
IS - 4
ER -